Pilot study: The influence of commonly used medicines in obstetric care on the fetal ECG Short title: FEMME (Fetal Ecg and Maternal MEdication)
- Conditions
- Complications during pregnancy10026908
- Registration Number
- NL-OMON43800
- Lead Sponsor
- Maxima Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 750
Pregnant women, carrying a healthy, singleton fetus with a gestational age between 20 and 42 weeks, receiving one or more of the following medicines; tocolytic drugs, corticosteroids, antihypertensive agents or medication for sedation or pain relief during labour. Patients receiving both tocolytic drugs and corticosteroids at the same time can participate in this study, since this is standard care nowadays. Also patients receiving antihypertensive agents and corticosteroids simultaneously can be included in this study. In this way, we will get information that is applicable in daily clinical practice.
Women under the age of 18 years old, using other medicines than examined in this study, multiple pregnancies, women carrying a fetus with a known congenital malformation and fetuses with an intra-uterine growth restriction are excluded (defined as a fetal growth lower than p5 as estimated by echography). Fetal congenital malformations discovered after inclusion will be analysed separately.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method